- Home
- ACIU vs SMLR Comparison
ACIU vs SMLR Comparison
Compare ACIU & SMLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIU
- SMLR
- Stock Information
- Founded
- ACIU 2003
- SMLR 2007
- Country
- ACIU Switzerland
- SMLR United States
- Employees
- ACIU N/A
- SMLR N/A
- Industry
- ACIU Biotechnology: Pharmaceutical Preparations
- SMLR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ACIU Health Care
- SMLR Health Care
- Exchange
- ACIU Nasdaq
- SMLR Nasdaq
- Market Cap
- ACIU 332.4M
- SMLR 289.5M
- IPO Year
- ACIU 2016
- SMLR 2014
- Fundamental
- Price
- ACIU $3.21
- SMLR $60.71
- Analyst Decision
- ACIU Strong Buy
- SMLR
- Analyst Count
- ACIU 2
- SMLR 0
- Target Price
- ACIU $12.00
- SMLR N/A
- AVG Volume (30 Days)
- ACIU 137.8K
- SMLR 1.1M
- Earning Date
- ACIU 11-05-2024
- SMLR 11-04-2024
- Dividend Yield
- ACIU N/A
- SMLR N/A
- EPS Growth
- ACIU N/A
- SMLR N/A
- EPS
- ACIU N/A
- SMLR 2.04
- Revenue
- ACIU $48,505,404.00
- SMLR $58,938,000.00
- Revenue This Year
- ACIU N/A
- SMLR N/A
- Revenue Next Year
- ACIU $938.44
- SMLR N/A
- P/E Ratio
- ACIU N/A
- SMLR $27.98
- Revenue Growth
- ACIU 4097200.00
- SMLR N/A
- 52 Week Low
- ACIU $2.25
- SMLR $20.88
- 52 Week High
- ACIU $5.14
- SMLR $79.45
- Technical
- Relative Strength Index (RSI)
- ACIU 48.25
- SMLR 62.87
- Support Level
- ACIU $3.29
- SMLR $52.00
- Resistance Level
- ACIU $3.48
- SMLR $63.29
- Average True Range (ATR)
- ACIU 0.22
- SMLR 8.79
- MACD
- ACIU 0.01
- SMLR 0.29
- Stochastic Oscillator
- ACIU 23.86
- SMLR 48.35
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About SMLR Semler Scientific Inc.
Semler Scientific Inc is a United States based company that is engaged in providing technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. It focuses on developing, manufacturing, and marketing proprietary products and services that assist customers, including insurance plans, physicians, and risk assessment groups, in evaluating and treating chronic diseases. The company markets its vascular-testing product under the QuantaFlo brand, which is a four-minute in-office blood flow test.